RN7SL223P

Across TCGA pan-cancer cohorts, RN7SL223P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RN7SL223P data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher RN7SL223P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL223P expression acts as an unfavorable survival marker.

PAAD, CESC, and KIRC are the cancer types where RN7SL223P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	OS	Tertile	All	0.140	0.590	<.001	72	view →
CESC	OS	Tertile	III,IV	0.146	0.657	.015	36	view →
KIRC	DFS	Tertile	IV	0.127	0.630	.039	18	view →
LGG	OS	Tertile	All	0.551	0.909	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RN7SL223P–PAAD (OS)

Open the PAAD breakdown →